Day Three: Wednesday, April 29, 2015

Reshaping Innovation Through Electronic Health


  • Gregg Meyer, MD
    Chief Clinical Officer, Partners HealthCare
  • Judy Faulkner
    CEO and Founder, EPIC Systems

Gene Editing, Gene Therapy, and the Eye as a Gateway

  • Jennifer Joe, MD
    CEO, Medstro, Editor-In-Chief, MedTech Boston
  • Katrine Bosley
    CEO, Editas Medicine
  • Eric Pierce, MD, PhD
    Director, Retinal Degenerations Service, Massachusetts Eye and Ear; Solman and Libe Friedman Associate Professor of Ophthalmology, Harvard Medical School
  • Philip Gregory, D. Phil
    Senior Vice President, Research and CSO, Sangamo BioSciences
  • David Meeker, MD
    CEO, Genzyme

MS Transformed: Harnessing Biology and Inflammation

  • Mallika Marshall, MD
    Medical Reporter, WBZ-TV Boston
  • Tim Coetzee, PhD
    Chief Advocacy, Services, and Research Officer, National Multiple Sclerosis Society
  • Al Sandrock, MD, PhD
    Group Senior Vice President, Chief Medical Officer, Biogen
  • Howard Weiner, MD
    Founder and Director, Partners Multiple Sclerosis Center; Robert L. Kroc Professor of Neurology, Harvard Medical School
  • Michael Panzara, MD
    Group Vice President, Therapeutic Area Head, Multiple Sclerosis and Neurology, Genzyme